Terms: = Pancreatic cancer AND MET, RCCP2, 4233, ENSG00000105976, P08581, HGFR, AUTS9 AND Prognosis
156 results:
1. Identify novel inflammation-related prognostic signature in pancreatic cancer patients.
Sun Y; Zhang X; Zhu H
Medicine (Baltimore); 2024 Feb; 103(7):e36932. PubMed ID: 38363947
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes of Salvage Surgery Versus Non-Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma After Conversion Therapy with Transcatheter Arterial Chemoembolization Combined with Lenvatinib Plus Anti-PD-1 Antibody: A Multicenter Retrospective Study.
Wu JY; Wu JY; Fu YK; Ou XY; Li SQ; Zhang ZB; Zhou JY; Li B; Wang SJ; Chen YF; Yan ML
Ann Surg Oncol; 2024 May; 31(5):3073-3083. PubMed ID: 38316732
[TBL] [Abstract] [Full Text] [Related]
3. KIF20B and met, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression.
Cao Z; Guan M; Cheng C; Wang F; Jing Y; Zhang K; Jiao J; Ruan L; Chen Z
Pathol Res Pract; 2024 Feb; 254():155046. PubMed ID: 38266456
[TBL] [Abstract] [Full Text] [Related]
4. EPYC functions as a novel prognostic biomarker for pancreatic cancer.
Yang Z; Li H; Hao J; Mei H; Qiu M; Wang H; Gao M
Sci Rep; 2024 Jan; 14(1):719. PubMed ID: 38184732
[TBL] [Abstract] [Full Text] [Related]
5. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract] [Full Text] [Related]
6. Serum Lipid Level in Evaluating Chinese pancreatic Neuroendocrine Neoplasms: A Retrospective Study.
Gu D; Xue B; Zhu G; Xu Y; Yan L; Tang Q; Lu C
Exp Clin Endocrinol Diabetes; 2024 Feb; 132(2):98-106. PubMed ID: 38096919
[TBL] [Abstract] [Full Text] [Related]
7. Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer.
Li D; Weng S; Zeng K; Xu H; Wang W; Shi J; Chen J; Chen C
Gene; 2024 Feb; 895():148007. PubMed ID: 37981080
[TBL] [Abstract] [Full Text] [Related]
8. High expression ITGA2 affects the expression of met, PD-L1, CD4 and CD8 with the immune microenvironment in pancreatic cancer patients.
Jin L; Duan Y; Li X; Li Z; Hu J; Shi H; Su Z; Li Z; Du B; Chen Y; Tan Y
Front Immunol; 2023; 14():1209367. PubMed ID: 37881431
[TBL] [Abstract] [Full Text] [Related]
9. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
Liu J; Zhu X; Pan Y; Zhong J; Jin R; Zheng X; Zhang W; Hu K; Ma J; Shi X; Liu H; Yang X; Xu D; Ma C; Chen J; Wang D; Wang X; Li Z; Zhao L; Zhang L; Li T; Liu F; Tan G; Xing B; Zhao H; Zeng Y; Zhang S; Zhang L; Zhou L; Song T; Yang W; Liang X; Xiang B; Xu L; Sun H; Wang K
Oncologist; 2024 Apr; 29(4):e487-e497. PubMed ID: 37874924
[TBL] [Abstract] [Full Text] [Related]
10. Clinicopathological and prognostic values of met expression in pancreatic adenocarcinoma based on bioinformatics analysis.
Yao Y; Zhan R; Gong C; Lv J; Lu X
Medicine (Baltimore); 2023 Oct; 102(41):e34656. PubMed ID: 37832054
[TBL] [Abstract] [Full Text] [Related]
11. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer.
Zhang B; Chen X; Wang Z; Guo F; Zhang X; Huang B; Ma S; Xia S; Shang D
Aging (Albany NY); 2023 Oct; 15(19):10549-10579. PubMed ID: 37815881
[TBL] [Abstract] [Full Text] [Related]
12. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
[TBL] [Abstract] [Full Text] [Related]
13. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas.
Napoli N; Kauffmann EF; Ginesini M; Lami L; Lombardo C; Vistoli F; Campani D; Boggi U
Updates Surg; 2023 Sep; 75(6):1481-1496. PubMed ID: 37535191
[TBL] [Abstract] [Full Text] [Related]
14. Molecular and Functional Heterogeneity of Primary pancreatic Neuroendocrine Tumors and metastases.
Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
[TBL] [Abstract] [Full Text] [Related]
15. Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Gudmundsdottir H; Habermann EB; Vierkant RA; Starlinger P; Thiels CA; Warner SG; Smoot RL; Truty MJ; Kendrick ML; Halfdanarson TR; Nagorney DM; Cleary SP
Ann Surg Oncol; 2023 Aug; 30(8):4840-4851. PubMed ID: 37208566
[TBL] [Abstract] [Full Text] [Related]
16. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
[TBL] [Abstract] [Full Text] [Related]
17. Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings.
Malcolm JA; Tacey M; Gibbs P; Lee B; Ko HS
Eur Radiol; 2023 Oct; 33(10):6659-6669. PubMed ID: 37079029
[TBL] [Abstract] [Full Text] [Related]
18. Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms.
Elvebakken H; Hjortland GO; Garresori H; Andresen PA; Janssen EAM; Vintermyr OK; Lothe IMB; Sorbye H
J Neuroendocrinol; 2023 Apr; 35(4):e13256. PubMed ID: 37017614
[TBL] [Abstract] [Full Text] [Related]
19. Elevated Alfa-Fetoprotein and Des-Gamma-Carboxy Prothrombin Levels Predict Poor Outcomes After Liver Transplantation for Hepatocellular Carcinoma Beyond the Japan Criteria.
Ishii M; Ibuki S; Morinaga J; Shimata K; Hirukawa K; Isono K; Honda M; Sugawara Y; Inomata Y; Hibi T
Transplant Proc; 2023 Apr; 55(3):606-612. PubMed ID: 37005157
[TBL] [Abstract] [Full Text] [Related]
20. Preoperative acute pancreatitis and hyperenzymemia are associated with poor prognosis in patients with nonfunctional pancreatic neuroendocrine tumors.
Song H; Tan Q; Yuan Y; Liu X; Chen Y; Wang X
J Surg Oncol; 2023 Jun; 127(7):1135-1142. PubMed ID: 36912877
[TBL] [Abstract] [Full Text] [Related]
[Next]
